Allspring Global Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,302
Closed -$31.3K 2315
2023
Q3
$31.3K Buy
+1,302
New +$32K ﹤0.01% 2405
2022
Q2
Sell
-162
Closed -$5K 2728
2022
Q1
$5K Buy
+162
New +$4.54K ﹤0.01% 2980

Other funds holding CLB

Allspring Global Investments's CLB Position: Q4 2023 in Review

Allspring Global Investments sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 1,302 shares — an estimated $31.3K sold.

Allspring Global Investments first reported a position in CLB in Q1 2022 and held it in 2 quarters. The position peaked at $31.3K in Q3 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Allspring Global Investments reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 1,302 Core Laboratories shares in Q4 2023, an estimated $31.3K.
  • Allspring Global Investments first reported a position in Core Laboratories in Q1 2022 and held it in 2 quarters.
  • Allspring Global Investments's Core Laboratories position peaked at $31.3K in Q3 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.